Relmada Therapeutics, Inc. (RLMD)

3.735 -0.20 (-5.20%) USD  |  NASDAQ  |  Jan 21, 12:47
More

Relmada Therapeutics Hold Recommendations

Hold Recommendations Chart

View Hold Recommendations for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Hold Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Hold Recommendations Range, Past 5 Years

View Hold Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Hold Recommendations Benchmarks

View Hold Recommendations Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Invivyd, Inc. Upgrade
Arcellx, Inc. Upgrade
Puma Biotechnology, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade